170 related articles for article (PubMed ID: 25004356)
1. Microarray analysis: elegant, accurate, and expensive.
Wenstrom KD
Obstet Gynecol; 2014 Aug; 124(2 Pt 1):199-201. PubMed ID: 25004356
[No Abstract] [Full Text] [Related]
2. Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort.
Pergament E; Cuckle H; Zimmermann B; Banjevic M; Sigurjonsson S; Ryan A; Hall MP; Dodd M; Lacroute P; Stosic M; Chopra N; Hunkapiller N; Prosen DE; McAdoo S; Demko Z; Siddiqui A; Hill M; Rabinowitz M
Obstet Gynecol; 2014 Aug; 124(2 Pt 1):210-218. PubMed ID: 25004354
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing.
Dar P; Curnow KJ; Gross SJ; Hall MP; Stosic M; Demko Z; Zimmermann B; Hill M; Sigurjonsson S; Ryan A; Banjevic M; Kolacki PL; Koch SW; Strom CM; Rabinowitz M; Benn P
Am J Obstet Gynecol; 2014 Nov; 211(5):527.e1-527.e17. PubMed ID: 25111587
[TBL] [Abstract][Full Text] [Related]
4. Screening for fetal aneuploidy.
Rink BD; Norton ME
Semin Perinatol; 2016 Feb; 40(1):35-43. PubMed ID: 26725144
[TBL] [Abstract][Full Text] [Related]
5. Increased risk after noninvasive prenatal screening on cell-free DNA circulating in maternal blood: does a new indication for invasive prenatal diagnosis require new criteria for confirmatory cytogenetic analysis?
Grati FR; Malvestiti F; Grimi B; Liuti R; Agrati C; Gaetani E; Milani S; Martinoni L; Zanatta V; Gallazzi G; Maggi F; Simoni G
Prenat Diagn; 2015 Mar; 35(3):308-9. PubMed ID: 25754154
[No Abstract] [Full Text] [Related]
6. Prenatal diagnosis of fetuses with increased nuchal translucency using an approach based on quantitative fluorescent polymerase chain reaction and genomic microarray.
Pan M; Han J; Zhen L; Yang X; Li R; Liao C; Li DZ
Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():164-7. PubMed ID: 26771907
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive prenatal screening for aneuploidy: positive predictive values based on cytogenetic findings.
Meck JM; Kramer Dugan E; Matyakhina L; Aviram A; Trunca C; Pineda-Alvarez D; Aradhya S; Klein RT; Cherry AM
Am J Obstet Gynecol; 2015 Aug; 213(2):214.e1-5. PubMed ID: 25843063
[TBL] [Abstract][Full Text] [Related]
8. Circulating fetal cell-free DNA fractions differ in autosomal aneuploidies and monosomy X.
Rava RP; Srinivasan A; Sehnert AJ; Bianchi DW
Clin Chem; 2014 Jan; 60(1):243-50. PubMed ID: 24046201
[TBL] [Abstract][Full Text] [Related]
9. Reflex antenatal DNA screening for Down syndrome.
Wald NJ; Huttly WJ; Bestwick JP; Aquilina J; Peregrine E
Prenat Diagn; 2015 Nov; 35(11):1154. PubMed ID: 26211510
[No Abstract] [Full Text] [Related]
10. Diagnostic accuracy of the BACs-on-Beads™ assay versus karyotyping for prenatal detection of chromosomal abnormalities: a retrospective consecutive case series.
Choy KW; Kwok YK; Cheng YK; Wong KM; Wong HK; Leung KO; Suen KW; Adler K; Wang CC; Lau TK; Schermer MJ; Lao TT; Leung TY
BJOG; 2014 Sep; 121(10):1245-52. PubMed ID: 24893808
[TBL] [Abstract][Full Text] [Related]
11. Patient choice and clinical outcomes following positive noninvasive prenatal screening for aneuploidy with cell-free DNA (cfDNA).
Dobson LJ; Reiff ES; Little SE; Wilkins-Haug L; Bromley B
Prenat Diagn; 2016 May; 36(5):456-62. PubMed ID: 26938930
[TBL] [Abstract][Full Text] [Related]
12. Prenatal diagnosis of trisomy 21, 18 and 13 by quantitative pyrosequencing of segmental duplications.
Tong H; Jin Y; Xu Y; Zou B; Ye H; Wu H; Kumar S; Pitman JL; Zhou G; Song Q
Clin Genet; 2016 Nov; 90(5):451-455. PubMed ID: 26948280
[TBL] [Abstract][Full Text] [Related]
13. Use of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening.
Wagner AJ; Mitchell ME; Tomita-Mitchell A
Clin Perinatol; 2014 Dec; 41(4):957-66. PubMed ID: 25459783
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
[TBL] [Abstract][Full Text] [Related]
15. DNA sequencing versus standard prenatal aneuploidy screening.
Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
[TBL] [Abstract][Full Text] [Related]
16. The influence of low molecular weight heparin medication on plasma DNA in pregnant women.
Grömminger S; Erkan S; Schöck U; Stangier K; Bonnet J; Schloo R; Schubert A; Prott EC; Knoll U; Stumm M; von Kalle C; Hofmann W
Prenat Diagn; 2015 Nov; 35(11):1155-7. PubMed ID: 26248743
[No Abstract] [Full Text] [Related]
17. Trends in timing of prenatal diagnosis and abortion for fetal chromosomal abnormalities.
Hume H; Chasen ST
Am J Obstet Gynecol; 2015 Oct; 213(4):545.e1-4. PubMed ID: 26070711
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive prenatal testing for fetal aneuploidy: charting the course from clinical validity to clinical utility.
Hui L
Ultrasound Obstet Gynecol; 2013 Jan; 41(1):2-6. PubMed ID: 23280734
[No Abstract] [Full Text] [Related]
19. The implications of non-invasive prenatal testing failures: a review of an under-discussed phenomenon.
Yaron Y
Prenat Diagn; 2016 May; 36(5):391-6. PubMed ID: 26941176
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience and follow-up with large-scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing.
Singh ON
Am J Obstet Gynecol; 2015 Aug; 213(2):253. PubMed ID: 25940612
[No Abstract] [Full Text] [Related]
[Next] [New Search]
